Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Return on Equity (2018 - 2025)

Historic Return on Equity for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to 0.22%.

  • Regenerative Medical Technology's Return on Equity fell 300.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.23% for FY2024, which is 2000.0% down from last year.
  • As of Q3 2025, Regenerative Medical Technology's Return on Equity stood at 0.22%, which was down 300.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Return on Equity registered a high of 12.62% during Q3 2021, and its lowest value of 0.01% during Q4 2022.
  • Over the past 5 years, Regenerative Medical Technology's median Return on Equity value was 0.22% (recorded in 2025), while the average stood at 1.22%.
  • In the last 5 years, Regenerative Medical Technology's Return on Equity soared by 124000bps in 2021 and then tumbled by -124700bps in 2022.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Return on Equity stood at 2.06% in 2021, then crashed by -100bps to 0.01% in 2022, then soared by 3210bps to 0.18% in 2023, then increased by 11bps to 0.21% in 2024, then rose by 9bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q3 2025, 0.13% for Q2 2025, and 0.16% during Q1 2025.